phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

World IVF Devices and Consumables Market

- Opportunities and Forecasts, 2014 -2020
 Report Code: LI 14124
 Pages: 106
 Format: PDF Exel CD_rom
pub_n Published: Jan 2014
tab_nTables: 50
aut_nAuthor(s):
   Attention: View Updated Version Of The Report

In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely popular treatments, which has assisted couples with infertility problems, single mothers and the LGBT community to procreate. The global IVF devices market would witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures and increased occurrences of gamete donations. Furthermore, rising health awareness on fertility issues, availability of IVF treatments, increasing disposable income and favorable reimbursement policies would further augment the market growth. Recent innovations in IVF technology, such as Embryoscope and capsule IVF, are anticipated to augment the demand of IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies and ethical considerations are likely to hinder the market growth. Increasing upsurge of fertility clinics and same sex marriages would offer lucrative growth opportunities in future. In addition, fertility tourism would provide ample growth opportunities especially in the developing economies. The global IVF devices and consumables market accounted for $1,252.8 million in 2014 and is forecast to garner $3,627.2 million by 2020, registering a promising CAGR of 19.2% during the forecast period.

The global IVF devices market comprises five key segments namely, IVF instruments, reagents and media, technology, end users and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator is the highest revenue-generating segment owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment would witness a significant growth due to its extensive use in healthy sperm selection and gender determination.

Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue-generating segment due to its extensive use in frozen IVF cycles. IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique and donor egg transfer technique. In the current market scenario, fresh embryo transfer technique is the highest revenue-generating segment and would continue to maintain this trend during the forecast period owing to the higher user preference for this technique.

The global IVF devices market by end-users is segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. Fertility clinics is the highest revenue-generating segment in the IVF market due to easy accessibility of IVF treatment and services and high success rates. Furthermore, surgical centers is forecast to exhibit rapid growth due to the use of sophisticated IVF technologies.

The global IVF devices market has been analyzed on the basis of geographical regions, which include North America, Europe, Asia Pacific and LAMEA. Europe and North America are the dominant regions of this market, collectively accounting for about 79% of the total market share. This is mainly attributed to the widespread adoption of advanced technologies, healthcare awareness, favorable reimbursement policies and supportive legal frameworks. Nevertheless, Asia Pacific would emerge as the fastest growing region owing to low manufacturing costs of IVF devices and increasing popularity of medical tourism. Moreover, availability of skilled personnel and rising awareness would further augment the market growth in this region.

The competitive landscape of the IVF devices market indicates the presence of local as well as global IVF device manufacturers. Product launch has been the prime growth strategy adopted by the major market players to improve their market share. Some of the prominent product launches include micromanipulators systems, ovum aspiration pumps and IVF accessories. These technologies are used in both clinical and research fields. The key companies profiled in this report include, Vitrolife AB, EMD Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology and OvaScience, Inc.

 1.1    KEY MARKET BENEFITS

  • An in-depth analysis of the current research and clinical developments in the global IVF devices market has been provided with key factors to understand the market scenario.
  • The projections in the report are based on the analysis of the current market trends and future market potential in terms of value during the period of 2014–2020.
  • An exhaustive analysis of the global IVF devices market by instruments helps in understanding the type of devices that are currently being used along with the variants that would gain prominence in future.
  • Competitive intelligence of leading manufacturers and distributors of IVF devices highlights the business practices followed by leading market players across various geographies.
  • SWOT analysis facilitates the study of the internal environment of prominent companies for strategy formulation.
  • A comprehensive analysis of the market has been conducted by closely monitoring key products of top contenders in the market.

1.2    KEY MARKET SEGMENTS

The global IVF devices market is segmented on the basis of instruments, reagents and media, techniques, end users and geography.

  • Global IVF Devices Market - By Instruments
    • Incubators
    • Cryosystem
    • Imaging system
    • Cabinet
    • Ovum aspiration pump
    • Sperm separation system
    • Accessories and disposables
    • Micromanipulator
    • Others
  • Global IVF Devices Market - By Reagents and Media
    • Cryopreservation media
    • Semen processing media
    • Ovum processing media
    • Embryo culture media
  • Global IVF Devices Market - By Technology
    • Fresh embryo transfer technique
    • Frozen embryo transfer technique
    • Donor egg IVF technique
  • Global IVF Devices Market - By End Users
    • Fertility clinics
    • Hospitals
    • Surgical centers
    • Clinical research institutes
  • Global IVF Devices Market - By Geography
    • North America 
      • USA
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • United Kingdom
      • Other Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Other APAC
    • LAMEA
      • Latin America
      • Middle East
      • Africa
Table Of Content
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1 617 674 4143 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name Price

Chapter: 1    INTRODUCTION

1.1    Report Description
1.2    KEY MARKET BENEFITS
1.3    KEY MARKET SEGMENTS
1.1    Research methodology
1.1.1    Secondary research
1.1.2    Primary research
1.1.3    Analyst tools and models

$0(SU) €0(SU) £0(SU)

Chapter: 2    EXECUTIVE SUMMARY

$195(SU) €0(SU) £0(SU)

Chapter: 3    GLOBAL IVF DEVICES AND CONSUMABLES MARKET OVERVIEW

3.1    Market definition and scope
3.2    Alternative Technologies
3.2.1    Intrauterine Insemination (IUI) Technique
3.2.1.1    Factors assessed for the procedure
3.2.1.2    Benefits of this technique
3.2.1.3    Risks
3.2.2    Difference between IUI and IVF technique
3.2.3    GIFT technique
3.2.3.1    Difference between GIFT and IVF technique
3.2.4    ZIFT technique
3.2.4.1    Differences between ZIFT and IVF technique
3.3    Replacing IVF procedures by fertility drugs and surgeries
3.3.1    Female infertility treatments
3.3.1.1    Limitations of fertility drugs
3.3.2    Male infertility treatments
3.4    Costs related to IVF procedures
3.5    Role of donors in the IVF market
3.5.1    Egg donation
3.5.2    Egg sharing
3.5.3    Sperm donation
3.5.4    Embryo donation/adoption
3.5.5    Donation for research
3.6    Surrogacy
3.6.1    Legal issues
3.7    IVF trends in same sex couples
3.7.1    Artificial insemination
3.7.2    Surrogate mothers
3.7.3    In-vitro fertilization
3.8    Advanced IVF technologies
3.8.1    Capsule IVF
3.8.2    Three parent IVF
3.8.2.1    Ethical concerns
3.8.3    Mini IVF
3.8.3.1    Advantages
3.8.3.2    Drawbacks
3.8.4    EmbryoScope
3.8.4.1    Advantages
3.8.5    PICSI
3.9    Fertility treatment and Gender selection
3.9.1    Methods of sex selection
3.9.1.1    Gradient method
3.9.1.2    Flow cytometry technique
3.9.1.3    Pre-implantation genetic diagnosis (PGD)
3.9.1.4    Ethical and legal issues
3.10    Metabolomics in embryo screening methods
3.11    Application of stem cells in IVF
3.12    IVF and resource poor countries
3.13    Key Findings
3.13.1    Top factors impacting
3.13.2    Top investment pockets
3.13.3    Top winning strategies
3.14    Porter’s five forces analysis
3.14.1    High competition and large number reduces the power of suppliers
3.14.2    Scattered nature and large count of end users moderates the buyer power
3.14.3    High capital cost lowers the threat of new entrants
3.14.4    Industry rivalry is intense due to presence of few dominant competitors
3.14.5    Lack of efficient substitutes lowers the threat from substitutes
3.15    Value chain analysis
3.16    Patent Analysis
3.16.1    Patent analysis by type of patents
3.16.2    Patents Analysis by geography
3.17    Regulatory issues and legislations
3.18    Insurance reimbursement scenario
3.19    Clinical trials
3.19.1    Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2    Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3    Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4    Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5    Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20    Drivers
3.20.1    Delayed pregnancies in women
3.20.2    Rise in global infertility rates
3.20.3    Advancement in technology
3.20.4    Rise in gamete donations
3.20.5    Rise in disposable income
3.20.6    Increase in success rates
3.21    Restraints
3.21.1    Cost constraints
3.21.2    Ethical and legal issues
3.21.3    Multiple pregnancies
3.21.4    Low awareness level
3.22    Opportunities
3.22.1    Fertility tourism
3.22.2    Growing number of fertility clinics
3.22.3    Rise in same sex marriages

$495(SU) €0(SU) £0(SU)

Chapter: 4    GLOBAL IVF DEVICES MARKET BY INSTRUMENTS

4.1    Global IVF market by instruments types, 2014-2020, ($million)
4.1.1    Incubators
4.1.1.1    Global IVF incubators market by geography
4.1.2    Cryosystem
4.1.2.1    Global IVF cryosystem market by geography
4.1.3    Imaging system
4.1.3.1    Global IVF Imaging system market by geography
4.1.4    Cabinet (work station)
4.1.4.1    Global IVF cabinets market by geography
4.1.5    Ovum aspiration pump
4.1.5.1    Global IVF ovum aspiration pump market by geography
4.1.6    Sperm separation system
4.1.6.1    Global IVF Sperm separation system market by geography
4.1.7    Micro Manipulator System
4.1.7.1    Global IVF Micromanipulator market by geography
4.1.8    Others
4.1.8.1    Global IVF other instruments market by geography
4.2    Accessories and disposables
4.2.1    Semen analysis chamber
4.2.2    Plastic ware
4.2.3    Oocyte retrieval needles
4.2.4    Miscellaneous disposables
4.2.5    Global IVF accessories and disposables market by geography

$995(SU) €0(SU) £0(SU)

Chapter: 5    GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA

5.1    Global IVF market by reagents and media types, 2014-2020, ($million)
5.2    Cryopreservation media
5.2.1    Embryo cryopreservation media
5.2.2    Sperm cryopreservation media
5.2.3    Oocyte cryopreservation media
5.2.4    Global IVF cryopreservation media market by geography
5.3    Semen processing media
5.3.1    Global IVF semen processing media market by geography
5.4    Ovum processing media
5.4.1    Global IVF ovum processing media market by geography
5.5    Embryo culture media
5.5.1    Global IVF embryo culture media market by geography

$795(SU) €0(SU) £0(SU)

Chapter: 6    GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE

6.1    Global IVF market, by technique, 2014-2020 ($Million)
6.2    Fresh Embryo transfer technique
6.2.1    Drivers
6.2.1.1    trends of Delayed pregnancies
6.2.1.2    Growing rates of infertility
6.2.2    Restraints
6.2.2.1    Cost involved in the treatment
6.2.2.2    reimbursements issues with fresh embryo ivf cycles
6.2.3    Global fresh embryo IVF cycle market, by geography
6.3    Frozen embryo transfer technique (FER)
6.3.1    Reasons to use this technique
6.3.2    Advantages of Frozen egg IVF technique
6.3.3    Disadvantages of frozen egg IVF technique
6.3.4    Global frozen egg IVF cycle market, by geography
6.4    Donor Egg IVF technique
6.4.1    Benefits of donor egg IVF technique
6.4.2    Risks associated with donor egg IVF cycle technique
6.4.3    Global donor egg IVF cycle market by geography

$895(SU) €0(SU) £0(SU)

Chapter: 7    GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS

7.1    Global IVF market by end users, 2014-2020 ($Million)
7.2    Hospitals
7.2.1    Global IVF hospitals enduser market by geography
7.3    Surgical centers
7.3.1    Global IVF surgical centers enduser market by geography
7.4    Clinical research institutes
7.4.1    Global IVF clinical research institutes enduser market by geography
7.5    Clinics
7.5.1    Global IVF Clinics endusers market by geography

$695(SU) €0(SU) £0(SU)

Chapter: 8    GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY

8.1    North America
8.1.1    North America IVF Devices and Consumables Market, By components
8.1.1.1    United States IVF devices and consumables market
8.1.1.2    Canada IVF devices and consumables market
8.1.1.3    Mexico IVF devices and consumables market
8.2    Europe
8.2.1    Europe IVF Devices and Consumables Market, By Component
8.2.1.1    Germany IVF devices and consumables market
8.2.1.2    France IVF devices and consumables market
8.2.1.3    United Kingdom IVF devices and consumables market
8.2.1.4    Other Europe IVF devices and consumables market
8.3    Asia-Pacific
8.3.1    Asia-Pacific IVF Devices and Consumables Market, By Component
8.3.1.1    India IVF devices and consumables market
8.3.1.2    China IVF devices and consumables market
8.3.1.3    Japan IVF devices and consumables market
8.3.1.4    Australia IVF devices and consumables market
8.3.1.5    other asia-pacific IVF devices and consumables market
8.4    LAMEA
8.4.1    LAMEA IVF Devices and Consumables Market, By Component
8.4.1.1    Latin America IVF devices and consumables market
8.4.1.2    Middle East IVF devices and consumables market
8.4.1.3    Africa IVF devices and consumables market

$795(SU) €0(SU) £0(SU)

Chapter: 9    COMPANY PROFILE

9.1    Vitrolife AB
9.1.1    Company overview
9.1.2    Business performance
9.1.3    Strategic moves and developments
9.1.4    SWOT Analysis of Vitrolife AB
9.2    EMD Serono, Inc.
9.2.1    Company overview
9.2.2    Business performance
9.2.3    Strategic moves and developments
9.2.4    SWOT Analysis of EMD Serono, Inc.
9.3    Irvine Scientific
9.3.1    Company overview
9.3.2    Business performance
9.3.3    Strategic moves and developments
9.3.4    SWOT Analysis of Irvine scientific
9.4    Cooper Surgical, Inc. (Origio)
9.4.1    Company overview
9.4.2    Business performance
9.4.3    Strategic moves and developments
9.4.4    SWOT Analysis of Cooper Surgical, Inc.
9.5    Cook Medical, Inc.
9.5.1    Company overview
9.5.2    Strategic moves and developments
9.5.3    SWOT Analysis of Cook medical, Inc.
9.6    Thermo Fisher Scientific Inc.
9.6.1    Company overview:
9.6.2    Business Performance
9.6.3    Strategic moves and developments
9.6.4    SWOT Analysis of Thermo Fisher Scientific, Inc.
9.7    Genea Biomedx
9.7.1    Company overview
9.7.2    Strategic moves and developments
9.7.3    SWOT Analysis of Genea Biomedx
9.8    Auxogyn, Inc.
9.8.1    Company overview
9.8.2    Strategic moves and developments
9.8.2.1    Primary strategies
9.8.2.2    Other strategies
9.8.3    SWOT Analysis of Auxogyn, Inc.
9.9    Oxford Gene Technology
9.9.1    Company overview
9.9.2    Strategic moves and developments
9.9.3    SWOT analysis of Oxford Gene Technology
9.10    Ovascience Inc.
9.10.1    Company overview
9.10.2    Business Performance
9.10.3    Strategic moves and developments
9.10.4    SWOT analysis of OvaScience, Inc.

 List of Figures

FIG. 1    IVF DEVICES MARKET DEFINITION
FIG. 2    ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY
FIG. 3    TOP IMPACTIG FACTORS (2014-2020)
FIG. 4    TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES MARKET (2014-2020)
FIG. 5    TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET 2012–2015
FIG. 6    TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET, 2012-2015
FIG. 7    PORTER’S FIVE FORCE ANALYSIS
FIG. 8    VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 9    PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)
FIG. 10    PATENT ANALYSIS BY GEOGRAPHY (2011-2015)
FIG. 11    EFFECT OF AGE ON FERTILITY
FIG. 12    COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 13    SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.
FIG. 14    PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)
FIG. 15    VITROLIFE AB, SALES PER REGION, 2014
FIG. 16    VITROLIFE AB, REVENUES ($MILLION), 2012-2014
FIG. 17    SWOT ANALYSIS OF VITROLIFE AB
FIG. 18    EMD SERONO SALES BY REGION, 2012
FIG. 19    SWOT ANALYSIS OF EMD SERONO, INC.
FIG. 20    SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 21    SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIG. 22    SWOT ANALYSIS OF COOK MEDICAL, INC.
FIG. 23    THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 24    FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)
FIG. 25    SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIG. 26    SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 27    SWOT ANALYSIS OF AUXOGYN, INC.
FIG. 28    SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 29    SWOT ANALYSIS OF OVASCIENCE, INC.

 List of Tables

TABLE 1    COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2    COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3    COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4    COST OF DONOR EGG PROCEDURE IN UNITED STATES (2014)
TABLE 5    COST OF SPERM DONATION (2014)
TABLE 6    AVERAGE SURROGACY COSTS, 2014
TABLE 7    COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 8    COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 9    APPLICATIONS OF PGD TECHNOLOGY
TABLE 10 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015
TABLE 11 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012–2015
TABLE 12 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015
TABLE 13 INSURANCE COVERAGE FOR COUNTRIES
TABLE 14 INFERTILITY RATES IN NORTH AMERICA
TABLE 15 GLOBAL DISPOSABLE INCOME, 2014-2021
TABLE 16 IVF SUCCESS RATES BY AGE, EUROPE
TABLE 17 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENTS TYPES, 2014-2020 ($MILLION)
TABLE 18 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 19 GLOBAL IVF INCUBATORS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 GLOBAL IVF CRYOSYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL IVF IMAGING SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL IVF CABINETS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 23 GLOBAL IVF OVUM APIRATION PUMP MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 25 GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 26 GLOBAL IVF MICROMANIPULATOR MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL IVF OTHER INSTRUMENTS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION)
TABLE 30 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 31 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 32 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 33 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 34 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 35 GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 36 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 37 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 38 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2020 ($MILLION)
TABLE 39 GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 40 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 41 GLOBAL FROZEN EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 42 GLOBAL DONOR EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 43 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2020 ($MILLION)
TABLE 44 GLOBAL IVF HOSPITALS ENDUSER MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 45 GLOBAL IVF SURGICAL CENTERS ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 46 GLOBAL IVF CLINICAL RESEARCH INSTITUTES ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 47 GLOBAL IVF CLINICS ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 48 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 2014–2020 ($MILLION)
TABLE 49 REGULATORY SCENARIO, NORTH AMERICA
TABLE 50 NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014–2020 ($MILLION)
TABLE 51 EUROPE IVF CYCLES IN 2014
TABLE 52 REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE
TABLE 53 REGULATORY SCENARIO, EUROPE
TABLE 54 EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014–2020 ($MILLION)
TABLE 55 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 56 ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014–2020 ($MILLION)
TABLE 57 TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS
TABLE 58 REGULATORY SCENARIO, LAMEA
TABLE 59 LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 2014–2020 ($MILLION)
TABLE 60 VITROLIFE AB BUSINESS SNAPSHOT
TABLE 61 EMD SERONO, INC BUSINESS SNAPSHOT
TABLE 62 IRVINE SCIENTIFIC BUSINESS SNAPSHOT
TABLE 63 COOPER SURGICAL, INC. BUSINESS SNAPSHOT
TABLE 64 COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 65 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 66 GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 67 AUXOGYN, INC. BUSINESS SNAPSHOT
TABLE 68 OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT
TABLE 69 OVASCIENCE, INC. BUSINESS SNAPSHOT

 

$595(SU) €0(SU) £0(SU)

The IVF market analyzed in this report includes the various technologies of in-vitro fertilization along with the instruments, reagents and media used during the procedures. The market is segmented into instruments, reagents and media, technology and end users. This report excludes the in depth analysis of IVF in the service market and drugs market.

The scope of the market in the upcoming years is increase in technological advancement, high success rates, cost efficient treatments, and uncomplicated procedures that would save both the patients as well as the doctor’s time.

This market has growth opportunities in the geographic areas such as Asia pacific and RoW, where the rate of infertility is increasing and need for better IVF techniques that are cost efficient.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User $4515
Group User $5325
Site User $7350
Global User $10680
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    The digital pathology is a new technology that has digitalized the instruments used in the pathology labs for testing. The digitalization has led to the automation of the tests done during the diagnosis procedures. For example, a single digital instrument operated by a single pathologist can perform tests that were previously done using five instruments. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. Automation in the conventional methods of pathology is the major driving force of this market, which has resulted in workflow efficiency, efficiency in analysis.
    Mar 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulates unsafe injection practices.
    Jan 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam.
    Oct 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Enzymes have gathered a special attention in the recent years due to its potential application in the several industries such as food & animal feed, textiles and Surfactants, pharmaceuticals & biotechnology R&D and manufacturing and others (paper and pulp processing, leather processing and agriculture).
    Sep 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Nerve regeneration is a process used in the repair and replacement of damage nervous tissues, cells and cellular products. The nerve repair mechanism is generally used in the new glial cells, nervous, myelin, axons and synapse. The report is chiefly emphasizing on the commercial market of nerve repair and regeneration market. The rise in incidences of chronic diseases and increase in demand for the advance health care technologies is allowing health care industry to widen its presence in this market.
    Mar 2016 | View Details >>
  • ...
    Obesity is a medical term used when excessive accumulation of fat occurs in the body. It may have numerous adverse effects on health, which increases the chances of occurrence of diseases and ultimately reduces life expectancy of an individual. Some of the diseases to which an obese individual is prone include type II diabetes, heart diseases, osteoarthritis and even certain types of cancer. One-third of adults in the U.S are obese. The rising pace of obesity and chronic diseases is creating the need for weight loss programs and obesity management.
    Mar 2016 | View Details >>
  • ...
    Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to wrong signal sent by nerve cells to the brain. Antiepileptic drugs also act as mood stabilizers and also used in the treatment of bipolar disorders or neuropathic pain. Antiepileptics market is specifically driven due to new drug approvals over the past few years. However, recent patent expiration of major brand such as Lamictal is expected to hinder the growth of the market. GlaxoSmithKline, Johnson & Johnson, Sanofi, Pfizer, Novartis, Abbott, Sunovion Pharmaceuticals, and Cephalon are some of the key leaders of global antiepileptic drugs market.
    Mar 2016 | View Details >>
  • ...
    Wearable medical devices are handheld monitoring tools used in identification and monitoring of disease. Due to the Increase in chronic diseases, patients are opting home healthcare as a cost effective and efficient way of treatment, rather than hospital services. Medical device market accounted for $240 billion in 2013. However, increase in incidence of chronic diseases restricts the growth of wearable medical device market.
    Mar 2016 | View Details >>